Theodosia A. Kalfa, MD, PhD
- Co-Director, Erythrocyte Diagnostic Laboratory
- Professor, UC Department of Pediatrics
- theodosia.kalfa@cchmc.org
- Board Certified
About
MD: Aristotle University Medical School, Thessaloniki, Greece, 1990.
PhD: Aristotle University Medical School, Thessaloniki, Greece, 1997.
Residency: University Of North Carolina, Chapel Hill, NC, 1999.
Fellowship: Duke University Medical Center, Durham, NC, 2003.
Certification: Hematology / oncology, American Board of Pediatrics, 2004; Pediatrics, American Board of Pediatrics, 2000; ECFMG Certification, 1995.
Licenses: Full and unrestricted medical license (OH Medical Board), 2003-present; full and unrestricted license of medical practice in Greece, 1990-present.
Services and Specialties
Cancer and Blood Diseases, Sickle Cell and Hemoglobin Disorders
Interests
Signaling in erythrocytes; erythropoiesis; sickle cell disease; reactive oxygen species
Research Areas
Experimental Hematology and Cancer Biology, Hematology, Cancer and Blood Diseases
Additional Languages
Greek
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects. The American Journal of Human Genetics. 2020; 107:1149-1156.
Red cell membrane disorders: structure meets function. Blood. 2020; 136:1250-1261.
Signaling and cytoskeletal requirements in erythroblast enucleation. Blood. 2012; 119:6118-6127.
Inducible Knockout of Codanin-1: An Adult Mouse Model of Congenital Dyserythropoietic Anemia Type-I. Blood. 2023; 142:2450.
Irf5 Expression in Macrophages Contributes to Iron Regulation within Erythromyeloblastic Islands. Blood. 2023; 142:920.
Rapid Assessment of Hemoglobin-Oxygen Dissociation. Blood. 2023; 142:2270.
Leveraging Transcriptomic Data to Study Erythromyeloblastic Island (EMBI) Macrophages: Using Spic-GFP As a Marker for Embi Macrophages. Blood. 2023; 142:3832.
Erythrocyte Disorders Mimicking Congenital Dyserythropoietic Anemia Based on Bone Marrow Pathology Exposed By Genetic Evaluation. Blood. 2023; 142:2459.
Congenital Dyserythropoietic Anemia Type II: An Update from the Congenital Dyseryhtropoietic Anemia Registry of North America (CDAR). Blood. 2023; 142:1079.
A Novel Beta Globin Frameshift Mutation Causing Autosomal Dominant Beta Thalassemia. Blood. 2023; 142:1105.
From the Blog
Blood Cell Production Discovery Opens Path to Improve Anemia of Inflammation
Theodosia A. Kalfa, MD, PhD10/31/2022
Rare Disease Day: More Tools for Solving Diagnostic Mysteries
Theodosia A. Kalfa, MD, PhD, Loren DM Pena, MD, PhD3/1/2021
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey